Document Type : Original Article
Authors
1
Department of Nuclear Medicine, Rajaee Heart Institute, Iran University of Medical Sciences, Tehran, Iran
2
Department of Nuclear Medicine, Rasoul Hospital, Iran University of Medical Sciences, Tehran, Iran
3
Department of Nuclear Medicine, Hasheminezhad Hospital, Iran University of Medical Sciences, Tehran, Iran
4
Department of Radiation Oncology, Hasheminezhad Hospital, Iran University of Medical Sciences, Tehran, Iran
5
Department of Urology, Hasheminezhad Hospital, Iran University of Medical Sciences, Tehran, Iran
6
Department of Nuclear Medicine, Kosar Hospital, Kurdistan University of Medical Sciences, Sanandaj, Iran
Abstract
Intoduction: Due to high expenses and lack of wide availability of [68Ga]Ga-PSMA PET/CT scan, we aimed to evaluate [99mTc]Tc-MDP and [99mTc]Tc-PSMA scan findings in a cluster of prostate cancer patients.
Methods: This prospective cross-sectional study was conducted from March 2021 to March 2022 at Shahid Hashemi Nejad hospital in Tehran, Iran. In this study, prostate cancer patients with intermediate to high-risk or patients with PSA rise during follow-up were selected for undergoing both [99mTc]Tc-MDP bone scintigraphy and [99mTc]Tc-PSMA scan. The scans were performed with a maximum 2-week interval. The images were evaluated for presence, number and locations of abnormal lesions. CT findings were used as an anatomical comparator; however, CT was not considered a true reference standard.
Results: 20 patients were evaluated. 63 bone lesions on CT scan, 69 lesions on [99mTc]Tc-MDP bone scan, 23 lesions on [99mTc]Tc-PSMA SPECT/CT and 16 lesions on [99mTc]Tc-PSMA planar images, were visualized. 56.3%, 31.1% and 31.1% of patients had positive conventional bone scan, [99mTc]Tc-PSMA SPECT/CT and planar [99mTc]Tc-PSMA images. Mean number of lesions on these modalities were 4.31±6.85, 1.43±3.75 and 1.00±2.30, respectively. Sensitivity rates of these three modalities were 100%, 55.6% and 55.6% while specificity was 100% for all of these modalities. Mean number of bone lesions on [99mTc]Tc-MDP bone scintigraphy and [99mTc]Tc-PSMA SPECT/CT showed significant difference (p=0.027).
Conclusion: In this cohort, [99mTc]Tc-MDP whole-body SPECT/CT scintigraphy identified a greater number of skeletal lesions than [99mTc]Tc-PSMA SPECT/CT. however, because a composite reference standard was unavailable, these findings should be interpreted as differences in lesion detection rather than definitive evidence of superior diagnostic performance. Larger prospective multicenter studies are warranted.
Keywords
Subjects